According to a new report Europe Artificial Intelligence in Diagnostics Market, published by KBV research, the Europe Artificial Intelligence in Diagnostics Market would witness market growth of 26.9% CAGR during the forecast period (2020-2026).
The Germany market dominated the Europe Hardware Market by Country in 2019, growing at a CAGR of 29.9 % during the forecast period. The UK market is exhibiting a CAGR of 29.5% during (2020 - 2026). Additionally, The France market is anticipated to witness a CAGR of 32.5% during (2020 - 2026).
The Neurology market dominated the Russia Artificial Intelligence in Diagnostics Market by Diagnosis Type in 2019, thereby, achieving a market value of $20.4 Million by 2026. The Oncology market is expected to witness a CAGR of 32.4% during (2020 - 2026).
The Software market dominated the Spain Artificial Intelligence in Diagnostics Market in 2019, growing at a CAGR of 33 % during the forecast period. The Services market is estimated to grow at a CAGR of 34.5% during (2020 - 2026). Additionally, The Hardware market is experiencing a CAGR of 31.6% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/europe-artificial-intelligence-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.
By Diagnosis Type
By Component
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
